https://cynata.com/activity-updates/P7Qn0e
ASX:CYP - Keep an eye on Cynata
Following the release of our ASX Quarterly Activity Report for the period ending 31 December 2024, leading small business journalist Tim Boreham covered our...
keep an eye onasxcyp
https://cynata.com/activity-updates/y0xAXy
ASX:CYP - Professor John Rasko discusses Cynata's iPSC technology on ABC Health Report
Listen to Professor John Rasko AO discussing the results of Cynata's Phase 1 clinical trial of CYP-001 in steroid-resistant acute GvHD, on the Australian...